Author:
Shida Seiji,Takahashi Naoto,Niioka Takenori,Kitabayashi Atsushi,Kawabata Yoshinari,Kume Masaaki,Saitoh Hirobumi,Hatano Yoshiaki,Ichikawa Yoshikazu,Kuroki Jun,Motegi Mutsuhito,Kobayashi Takahiro,Kameoka Yoshihiro,Tagawa Hiroyuki,Fujishima Naohito,Yoshioka Tomoko,Hirokawa Makoto,Miura Masatomo,Sawada Kenichi
Publisher
Japanese Society for Lymphoreticular Tissue Research
Reference19 articles.
1. 1 Kyle RA, Rajkumar SV: Multiple myeloma. Blood 111:2962-2972, 2008
2. 2 Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, et al.: Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 39:850-858, 2009
3. 3 Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, et al.: Improved survival in multiple myeloma and the impact of novel therapies. Blood 111:2516-2520, 2008
4. 4 Myeloma Trialists' Collaborative Group: Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group. J Clin Oncol 16:3832-3842, 1998
5. 5 Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, et al.: Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487-2498, 2005
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献